Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Martin T et al. – The data suggest that fungal prophylaxis with VOR following allogeneic transplantation is safe and effective.

Exclusive Author Commentary
Thomas Martin, 10/20/09

Voriconazole is a broad spectrum azole with activity against yeast and mould infections. When used as prophylaxis following allogeneic transplantation at UCSF Medical Center, very few patients experienced invasive fungal infection. This is true for both early fungal infection (within 10 days) and delayed fungal infection (>120 days). A weight based dosing strategy was used to optimized therapeutic drug delivery. Overall, the drug was well tolerated with few patients requiring dose interruption due to toxicity. An increased incidence of resistant invasive fungal infections was not seen.

Related Articles

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09    Relevance Score: 94%

Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09    Relevance Score: 94%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 94%

Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09    Relevance Score: 93%

Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 93%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address